Aptose Biosciences Inc (APTOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 05-2012 | 12-2011 | 05-2011 | 12-2010 | 05-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 830 | N/A | 1,840 | N/A |
| Other current assets | 0 | 460 | 0 | 500 | 0 |
| TOTAL | $N/A | $1,290 | $N/A | $2,340 | $N/A |
| Non-Current Assets | |||||
| PPE Net | N/A | 70 | N/A | 120 | N/A |
| Other Non-Current Assets | 0 | 0 | 0 | 590 | 0 |
| TOTAL | $N/A | $70 | $N/A | $710 | $N/A |
| Total Assets | $N/A | $1,360 | $N/A | $3,050 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 350 | 0 | 460 | 0 |
| Accrued Expenses | N/A | 1,080 | N/A | 1,240 | N/A |
| TOTAL | $N/A | $1,430 | $N/A | $1,700 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $1,430 | $N/A | $1,700 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4 | N/A | 3 | N/A | 55 |
| Common Shares | N/A | 167,620 | N/A | 163,630 | N/A |
| Retained earnings | N/A | -189,660 | N/A | -182,580 | N/A |
| Other shareholders' equity | 0 | 2,390 | 0 | 5,260 | 0 |
| TOTAL | $N/A | $-60 | $N/A | $1,340 | $N/A |
| Total Liabilities And Equity | $0 | $1,370 | $0 | $3,040 | $0 |